Summary
patients treated
Has anyone ever benefited from stem cell?
For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.
FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.
List of patients
| No. | Source | Source type | Diagnosis | Medical sector | Year of application | Therapy | Country | Age of the recipient |
|---|---|---|---|---|---|---|---|---|
| 6001 | Bone Marrow | Allogeneic | Digeorge Syndrome | Hematology | 2016 | Standard Therapy | Poland | 24 |
| 6002 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2016 | Standard Therapy | Poland | 7 |
| 6003 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2016 | Standard Therapy | Poland | 41 |
| 6004 | Bone Marrow | Allogeneic | High-Risk Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 18 |
| 6005 | Bone Marrow | Allogeneic | Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 17 |
| 6006 | Bone Marrow | Allogeneic | Hurler Syndrome | Metabolic | 2016 | Standard Therapy | Poland | 2 |
| 6007 | Bone Marrow | Allogeneic | Juvenile Myelomonocytic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 3 |
| 6008 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 1 |
| 6009 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 56 |
| 6010 | Bone Marrow | Allogeneic | Myelofibrosis | Hematology | 2016 | Standard Therapy | Poland | 31 |
| 6011 | Bone Marrow | Allogeneic | Myeloproliferative Syndrome | Hematology | 2016 | Standard Therapy | Poland | 22 |
| 6012 | Bone Marrow | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 3 |
| 6013 | Bone Marrow | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 7 |
| 6014 | Bone Marrow | Allogeneic | No Data | Hematology | 2016 | Standard Therapy | Poland | 33 |
| 6015 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 46 |
| 6016 | Bone Marrow | Allogeneic | Osteopetrosis | Metabolic | 2016 | Standard Therapy | Poland | 6 |
| 6017 | Bone Marrow | Allogeneic | Osteopetrosis | Metabolic | 2016 | Standard Therapy | Poland | 1 |
| 6018 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2016 | Standard Therapy | Poland | 9 |
| 6019 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2016 | Standard Therapy | Poland | 9 |
| 6020 | Bone Marrow | Allogeneic | Severe Aplastic Anemia; Paroxysmal Nocturnal Hemoglobinuria | Hematology | 2016 | Standard Therapy | Poland | 17 |
| 6021 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2016 | Standard Therapy | Poland | 2 |
| 6022 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2016 | Standard Therapy | Poland | 4 |
| 6023 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2016 | Standard Therapy | Poland | 7 months |
| 6024 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2016 | Standard Therapy | Poland | 12 |
| 6025 | Bone Marrow | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 4 |
| 6026 | Bone Marrow | Allogeneic | Thalassemia Major | Hematology | 2016 | Standard Therapy | Germany | 18 |
| 6027 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 56 |
| 6028 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 43 |
| 6029 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 61 |
| 6030 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 24 |
| 6031 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 13 |
| 6032 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 58 |
| 6033 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 20 |
| 6034 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 23 |
| 6035 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 27 |
| 6036 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 30 |
| 6037 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 37 |
| 6038 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 38 |
| 6039 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 28 |
| 6040 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 30 |
| 6041 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 39 |
| 6042 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 66 |
| 6043 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 20 |
| 6044 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 56 |
| 6045 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 9 |
| 6046 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 33 |
| 6047 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 21 |
| 6048 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 35 |
| 6049 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Germany | 57 |
| 6050 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Germany | 29 |
| 6051 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Germany | 1 |
| 6052 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Germany | 42 |
| 6053 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia – Relapse | Hematology | 2016 | Standard Therapy | Germany | 27 |
| 6054 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 58 |
| 6055 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 62 |
| 6056 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 40 |
| 6057 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 18 |
| 6058 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 66 |
| 6059 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 64 |
| 6060 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 54 |
| 6061 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 54 |
| 6062 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 18 |
| 6063 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 31 |
| 6064 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 35 |
| 6065 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 46 |
| 6066 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 29 |
| 6067 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 32 |
| 6068 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 49 |
| 6069 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 64 |
| 6070 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 42 |
| 6071 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 13 |
| 6072 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 8 |
| 6073 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 46 |
| 6074 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 40 |
| 6075 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 32 |
| 6076 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 66 |
| 6077 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 43 |
| 6078 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 66 |
| 6079 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 47 |
| 6080 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 15 |
| 6081 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 37 |
| 6082 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 57 |
| 6083 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 56 |
| 6084 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 52 |
| 6085 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 35 |
| 6086 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 72 |
| 6087 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 46 |
| 6088 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 51 |
| 6089 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 62 |
| 6090 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 69 |
| 6091 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 51 |
| 6092 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 55 |
| 6093 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 63 |
| 6094 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 65 |
| 6095 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 46 |
| 6096 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 18 |
| 6097 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 48 |
| 6098 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 67 |
| 6099 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 59 |
| 6100 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 9 months |